Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

273 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
COVID-19-associated risks and effects in myasthenia gravis (CARE-MG).
Muppidi S, Guptill JT, Jacob S, Li Y, Farrugia ME, Guidon AC, Tavee JO, Kaminski H, Howard JF Jr, Cutter G, Wiendl H, Maas MB, Illa I, Mantegazza R, Murai H, Utsugisawa K, Nowak RJ; CARE-MG Study Group. Muppidi S, et al. Among authors: illa i. Lancet Neurol. 2020 Dec;19(12):970-971. doi: 10.1016/S1474-4422(20)30413-0. Lancet Neurol. 2020. PMID: 33212055 Free PMC article. No abstract available.
Treatment strategies for myasthenia gravis.
Díaz-Manera J, Rojas-García R, Illa I. Díaz-Manera J, et al. Among authors: illa i. Expert Opin Pharmacother. 2009 Jun;10(8):1329-42. doi: 10.1517/14656560902950619. Expert Opin Pharmacother. 2009. PMID: 19445561 Review.
Long-lasting treatment effect of rituximab in MuSK myasthenia.
Díaz-Manera J, Martínez-Hernández E, Querol L, Klooster R, Rojas-García R, Suárez-Calvet X, Muñoz-Blanco JL, Mazia C, Straasheijm KR, Gallardo E, Juárez C, Verschuuren JJ, Illa I. Díaz-Manera J, et al. Among authors: illa i. Neurology. 2012 Jan 17;78(3):189-93. doi: 10.1212/WNL.0b013e3182407982. Epub 2012 Jan 4. Neurology. 2012. PMID: 22218276 Clinical Trial.
Treatment strategies for myasthenia gravis: an update.
Díaz-Manera J, Rojas García R, Illa I. Díaz-Manera J, et al. Among authors: illa i. Expert Opin Pharmacother. 2012 Sep;13(13):1873-83. doi: 10.1517/14656566.2012.705831. Epub 2012 Jul 9. Expert Opin Pharmacother. 2012. PMID: 22775575 Review.
Myasthenia gravis and the neuromuscular junction.
Querol L, Illa I. Querol L, et al. Among authors: illa i. Curr Opin Neurol. 2013 Oct;26(5):459-65. doi: 10.1097/WCO.0b013e328364c079. Curr Opin Neurol. 2013. PMID: 23945282 Review.
Analysis of serum miRNA profiles of myasthenia gravis patients.
Nogales-Gadea G, Ramos-Fransi A, Suárez-Calvet X, Navas M, Rojas-García R, Mosquera JL, Díaz-Manera J, Querol L, Gallardo E, Illa I. Nogales-Gadea G, et al. Among authors: illa i. PLoS One. 2014 Mar 17;9(3):e91927. doi: 10.1371/journal.pone.0091927. eCollection 2014. PLoS One. 2014. PMID: 24637658 Free PMC article.
273 results